-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Larimar Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
- Larimar Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $80K, a 2.56% increase year-over-year.
- Larimar Therapeutics, Inc. annual Depreciation for 2023 was $311K, a 2.2% decline from 2022.
- Larimar Therapeutics, Inc. annual Depreciation for 2022 was $318K, a 2.45% decline from 2021.
- Larimar Therapeutics, Inc. annual Depreciation for 2021 was $326K, a 110% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)